Oracle Investment Management
Latest statistics and disclosures from Oracle Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BHVN, SWTX, ARDX, WGS, EYPT, and represent 66.11% of Oracle Investment Management's stock portfolio.
- Added to shares of these 10 stocks: SWTX (+$13M), WGS (+$8.7M), ARDX (+$8.6M), Walgreens Boots Alliance (+$6.7M), BHVN, XBI, Biohaven, Staar Surgical, EYPT, CAVA.
- Started 6 new stock positions in WBA, CAVA, PLTR, OPTN, Staar Surgical, XBI.
- Reduced shares in these 10 stocks: Teladoc Inc call (-$14M), Quidelortho Corp (-$13M), Springworks Therapeutics (-$10M), Ardelyx Inc call (-$8.4M), Pacific Biosciences Calif In (-$5.8M), Eyepoint Pharmaceuticals, TDOC, QDEL, AGEN, .
- Sold out of its positions in Quidelortho Corp, INKT, TDOC, Teladoc Inc call, VTNR.
- Oracle Investment Management was a net seller of stock by $-5.7M.
- Oracle Investment Management has $151M in assets under management (AUM), dropping by -8.48%.
- Central Index Key (CIK): 0001012622
Tip: Access up to 7 years of quarterly data
Positions held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 27 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Biohaven (BHVN) | 29.2 | $44M | +12% | 805k | 54.69 |
|
| Springworks Therapeutics (SWTX) | 13.8 | $21M | +168% | 422k | 49.22 |
|
| Ardelyx (ARDX) | 9.9 | $15M | +135% | 2.0M | 7.30 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 6.8 | $10M | +531% | 1.1M | 9.13 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 6.3 | $9.5M | +15% | 462k | 20.67 |
|
| Walgreens Boots Alliance Call Call Option | 5.9 | $8.9M | +310% | 410k | 21.69 |
|
| Quidel Corp (QDEL) | 5.0 | $7.5M | -10% | 157k | 47.94 |
|
| Biohaven Call Call Option | 4.3 | $6.5M | +59% | 120k | 54.69 |
|
| Pacific Biosciences of California (PACB) | 3.4 | $5.1M | 1.4M | 3.75 |
|
|
| Forian Ord (FORA) | 3.0 | $4.5M | 1.4M | 3.32 |
|
|
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 2.2 | $3.3M | NEW | 35k | 94.89 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.8 | $2.7M | 536k | 5.08 |
|
|
| Springworks Therapeutics Call Call Option | 1.4 | $2.1M | -82% | 43k | 49.22 |
|
| Ardelyx Call Call Option | 1.3 | $2.0M | -80% | 271k | 7.30 |
|
| Staar Surgical Call Call Option | 0.9 | $1.3M | NEW | 35k | 38.28 |
|
| Immutep Sponsored Ads (IMMP) | 0.9 | $1.3M | +9% | 565k | 2.33 |
|
| Cava Group Ord (CAVA) | 0.8 | $1.2M | NEW | 18k | 70.05 |
|
| Pacific Biosciences Calif In Call Call Option | 0.6 | $938k | -86% | 250k | 3.75 |
|
| Agenus Com New (AGEN) | 0.4 | $619k | -24% | 1.1M | 0.58 |
|
| Walgreen Boots Alliance (WBA) | 0.4 | $597k | NEW | 28k | 21.69 |
|
| Eyepoint Pharmaceuticals Call Call Option | 0.4 | $591k | -87% | 29k | 20.67 |
|
| Palantir Technologies Call Call Option | 0.4 | $575k | NEW | 25k | 23.01 |
|
| Biogen Idec (BIIB) | 0.3 | $520k | 2.4k | 215.63 |
|
|
| Optinose (OPTN) | 0.3 | $475k | NEW | 325k | 1.46 |
|
| Biodesix (BDSX) | 0.0 | $43k | -50% | 30k | 1.43 |
|
| Accelerate Diagnostics Com New (AXDX) | 0.0 | $42k | -62% | 42k | 0.99 |
|
| Dermtech Ord ord (DMTK) | 0.0 | $34k | 48k | 0.70 |
|
Past Filings by Oracle Investment Management
SEC 13F filings are viewable for Oracle Investment Management going back to 2010
- Oracle Investment Management 2024 Q1 filed May 15, 2024
- Oracle Investment Management 2023 Q4 filed Feb. 14, 2024
- Oracle Investment Management 2023 Q3 filed Nov. 14, 2023
- Oracle Investment Management 2023 Q2 filed Aug. 14, 2023
- Oracle Investment Management 2023 Q1 filed May 15, 2023
- Oracle Investment Management 2022 Q4 filed Feb. 14, 2023
- Oracle Investment Management 2022 Q3 filed Nov. 14, 2022
- Oracle Investment Management 2022 Q2 filed Aug. 15, 2022
- Oracle Investment Management 2022 Q1 filed May 16, 2022
- Oracle Investment Management 2021 Q4 filed Feb. 14, 2022
- Oracle Investment Management 2021 Q3 filed Nov. 15, 2021
- Oracle Investment Management 2021 Q2 filed Aug. 16, 2021
- Oracle Investment Management 2021 Q1 filed May 17, 2021
- Oracle Investment Management 2020 Q4 filed Feb. 16, 2021
- Oracle Investment Management 2020 Q3 filed Nov. 16, 2020
- Oracle Investment Management 2020 Q2 filed Aug. 14, 2020